EDP Sciences logo
Subscriber Authentication Point
Rechercher
Menu
Accueil Tous les numéros Volume 41 / Numéro 11 (Novembre 2025) Med Sci (Paris), 41 11 (2025) 900-908 References
Open Access
Issue
Med Sci (Paris)
Volume 41, Number 11, Novembre 2025
Page(s) 900 - 908
Section Repères
DOI https://doi.org/10.1051/medsci/2025161
Published online 12 décembre 2025
  1. Fischer KL, Jaffredo M, Lang J, Raoux M. Cellules α et β du pancréas: meilleures ennemies ou partenaires pour la vie ?. Med Sci (Paris) 2021; 37 : 752–8. [Google Scholar]
  2. Vantyghem MC, de Koning EJP, Pattou F, Rickels MR. Advances in beta-cell replacement therapy for the treatment of type 1 diabetes. Lancet 2019; 394 : 1274–85. [Google Scholar]
  3. Shapiro AM, Lakey JR, Ryan EA, et al. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. The New Engl JMed 2000; 343 : 230–8. [Google Scholar]
  4. Marfil-Garza BA, Hefler J, Verhoeff K, et al. Pancreas and islet transplantation: comparative outcome analysis of a single-centre cohort over 20-years. Ann Surg 2023; 277 : 672–80. [Google Scholar]
  5. Lablanche S, Vantyghem MC, Kessler L, et al. Islet transplantation versus insulin therapy in patients with type 1 diabetes with severe hypoglycaemia or poorly controlled glycaemia after kidney transplantation (TRIMECO): a multicentre, randomised controlled trial. Lancet Diabetes Endocrinol 2018; 6 : 527–37. [CrossRef] [PubMed] [Google Scholar]
  6. Rickels MR, Robertson RP. Pancreatic islet transplantation in humans: recent progress and future directions. Endocr Rev 2019; 40 : 631–68. [Google Scholar]
  7. Hubert T, Arnalsteen L, Jany T, et al. Technique of pancreatic procurement for pancreatic islet isolation. Ann Chir 2005; 130 : 384–90. [Google Scholar]
  8. Maglio M, Goudot FX. Le prélèvement d’organes de type Maastricht 3 — Du discours bioéthique au langage ordinaire. Med Sci (Paris) 2023; 39 : 975–80. [Google Scholar]
  9. Hubert T, Gmyr V, Arnalsteen L, et al. Influence of preservation solution on human islet isolation outcome. Transplantation 2007; 83 : 270–6. [Google Scholar]
  10. Kerr-Conte J, Vandewalle B, Moerman E, et al. Upgrading pretransplant human islet culture technology requires human serum combined with media renewal. Transplantation 2010; 89 : 1154–60. [Google Scholar]
  11. Pasquetti GT, J. Chetboun, M. Apete, et al. In vivo quality control of human islets in the immunodeficient mouse to predict islet function in man: a retrospective study in 87 clinical transplants. In : Elsevier, ed. Transplantation, Bioengineering, and Regeneration of the Endocrine Pancreas 2019; 711–724. [Google Scholar]
  12. Caiazzo R, Vantyghem MC, Raverdi V, et al. Impact of procedure-related complications on long-term islet transplantation outcome. Transplantation 2015; 99 : 979–84. [Google Scholar]
  13. Vantyghem MC, Chetboun M, Gmyr V, et al. Ten-year outcome of islet alone or islet after kidney transplantation in type 1 diabetes: a prospective parallel-arm cohort study. Diabetes Care 2019; 42 : 2042–9. [Google Scholar]
  14. Mailliez A, Ternynck C, Jannin A, et al. Cognitive outcome after islet transplantation. Transplant Direct 2023; 9 : e1493. [Google Scholar]
  15. Maanaoui M, Lenain R, Foucher Y, et al. Islet-after-kidney transplantation versus kidney alone in kidney transplant recipients with type 1 diabetes (KAIAK): a population-based target trial emulation in France. Lancet Diabetes Endocrinol 2024; 12 : 716–24. [Google Scholar]
  16. Isenberg JS, Kandeel F. Can islet transplantation possibly reduce mortality in type 1 diabetes. Cell Transplant 2025; 34 : 9636897241312801. [Google Scholar]
  17. Perrier Q, Jambon-Barbara C, Kessler L, et al. Impact of islet transplantation on diabetes complications and mortality in patients living with type 1 diabetes. Diabetes Care 2025; 48 : 1007–15. [Google Scholar]
  18. Marfil-Garza BA, Imes S, Verhoeff K, et al. Pancreatic islet transplantation in type 1 diabetes: 20-year experience from a single-centre cohort in Canada. Lancet Diabetes Endocrinol 2022; 10 : 519–32. [Google Scholar]
  19. Catarinella D, Melzi R, Mercalli A, et al. Long-term outcomes of pancreatic islet transplantation alone in type 1 diabetes: a 20-year single-centre study in Italy. Lancet Diabetes Endocrinol 2025; 13 : 279–93. [Google Scholar]
  20. Ryan EA, Paty BW, Senior PA, et al. Beta-score: an assessment of beta-cell function after islet transplantation. Diabetes Care 2005; 28 : 343–7. [Google Scholar]
  21. Chetboun M LMK, Gmyr V et al. Optimizing primary graft function in islet allotransplantation: The Lille experience. In: Transplantation, Bioengineering, and Regeneration of the Endocrine pancreas : Academic Press, 2020 : 637–43. [Google Scholar]
  22. Chetboun M, Drumez E, Ballou C, et al. Association between primary graft function and 5-year outcomes of islet allogeneic transplantation in type 1 diabetes: a retrospective, multicentre, observational cohort study in 1210 patients from the Collaborative Islet Transplant Registry. Lancet Diabetes Endocrinol 2023; 11 : 391–401. [Google Scholar]
  23. Guignard AP, Oberholzer J, Benhamou PY, et al. Cost analysis of human islet transplantation for the treatment of type 1 diabetes in the Swiss-French Consortium GRAGIL. Diabetes Care 2004; 27 : 895–900. [Google Scholar]
  24. Chinnakotla S, Beilman GJ, Vock D, et al. Intraportal Islet Autotransplantation independently improves quality of life after total pancreatectomy in patients with chronic refractory pancreatitis. Ann Surg 2022; 276 : 441–9. [Google Scholar]
  25. Piemonti L, Melzi R, Aleotti F, et al. Autologous pancreatic islet cell transplantation following pancreatectomy for pancreas diseases other than chronic pancreatitis: a 15-y study of the milan protocol. Transplantation 2024; 108 : 1962–75. [Google Scholar]
  26. Vieira A, Druelle N, Courtney M, et al. Reprogrammation des cellules pancréatiques en cellules β. Med Sci (Paris) 2013; 29 : 749–55. [Google Scholar]
  27. Balboa D, Barsby T, Lithovius V, et al. Functional, metabolic and transcriptional maturation of human pancreatic islets derived from stem cells. Nature Biotechnol 2022; 40 : 1042–55. [Google Scholar]
  28. Wang S, Du Y, Zhang B, et al. Transplantation of chemically induced pluripotent stem-cell-derived islets under abdominal anterior rectus sheath in a type 1 diabetes patient. Cell 2024; 187 : 6152-64 e18. [Google Scholar]
  29. Matsumoto S, Matsumoto K. Clinical islet xenotransplantation: development of isolation protocol, anti-rejection strategies, and clinical outcomes. Cells 2024; 13. [Google Scholar]
  30. Piemonti L, Citro A, Tomajer V, et al. Pig xenotransplantation in beta cell replacement: addressing challenges and harnessing potential for type 1 diabetes therapy. Transpl Int 2024; 37 : 13122. [Google Scholar]
  31. Mallapaty S, Kozlov M. The science behind the first pig-organ transplant trial in humans. Nature 2025; 638 : 303–4. [Google Scholar]
  32. Reichman TW, Markmann JF, Odorico J, et al. Stem Cell-Derived, Fully Differentiated Islets for Type 1 Diabetes. N Engl JMed 2025 Jun 20. [Google Scholar]
  33. Berney T, Bellini MI, Montserrat N, et al. Reflecting on an intense year for transplant international. Transpl Int 2022; 35 : 11118. [Google Scholar]
  34. Wang Y, Peng F, Yang Z, et al. A rapid chemical reprogramming system to generate human pluripotent stem cells. Nat Chem Biol 2025. [Google Scholar]
  35. Scheiner ZS, Talib S, Feigal EG. The potential for immunogenicity of autologous induced pluripotent stem cell-derived therapies. J Biol Chem 2014; 289 : 4571–7. [Google Scholar]
  36. Strand BL, Coron AE, Skjak-Braek G. Current and Future Perspectives on Alginate Encapsulated Pancreatic Islet. Stem Cells Transl Med 2017; 6 : 1053–8. [Google Scholar]
  37. Cooper-Jones B, Ford C. CADTH horizon scans islet replacement therapy for insuilin-dependent diabetes. In: CADTH Issues in Emerging Health Technologies. Ottawa (ON) 2016 : 1–9. [Google Scholar]
  38. Desai T, Shea LD. Advances in islet encapsulation technologies. Nat Rev Drug Discov 2017; 16 : 338–50. [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.